SLC5A2 and sweet syndrome: Moreover, findings of fixed drug eruptions, SJS/TEN, drug-induced pruritus, and Sweet syndrome/acute febrile neutrophilic dermatosis have been linked with the commencement of SGLT2 inhibitors and subsided after discontinuing them.